Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial
NCT00963976
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Intracerebral Hemorrhage
Interventions
DRUG:
labetalol/hydralazine/enalapril
Sponsor
University of Alberta
Collaborators
[object Object]
[object Object]